8-K: Arteris Acquires Cycuity for Up to $45M in Cash & Stock

Arteris, Inc. is set to acquire Cycuity, Inc. in a two-step merger for up to $45 million, comprising cash and Arteris common stock, with an earnout tied to 2026 bookings.

Summary

• Arteris, Inc. is acquiring Cycuity, Inc. through a two-step merger and reorganization.
• The aggregate consideration for the acquisition is up to $45,000,000.
• Closing consideration includes $13,500,000 in cash and $19,500,000 in shares of Arteris common stock.
• An additional earnout consideration of up to $12,000,000, payable in Arteris common stock, is contingent upon Cycuity achieving specified bookings milestones for the 2026 calendar year.
• The number of shares issued will be based on the 30-day volume-weighted average price (VWAP) of Arteris common stock, subject to a collar mechanism with a lower bound of $12.42 and an upper bound of $16.80.
• A portion of the merger consideration will be deposited into escrow: $3,300,000 for indemnity claims (held for 12 months) and $330,000 for post-closing purchase price adjustments.
• The merger is intended to qualify as a reorganization for U.S. federal income tax purposes under Section 368(a) of the Code.
• Arteris will establish an $8,000,000 retention pool of Parent restricted stock units for Cycuity employees who remain employed post-closing.

Sentiment

Score: 7

Explanation: The acquisition represents a strategic expansion for Arteris into AI and security, with a significant portion of the consideration tied to future performance, indicating confidence but also inherent risk in achieving earnout targets. The retention pool for employees is a positive for integration.

Positives

• Strategic acquisition for Arteris, expanding its business capabilities, likely in AI technologies and security given Cycuity's product focus (Radix).
• The earnout structure provides an opportunity for Cycuity shareholders to receive additional value based on the future performance of the acquired business, aligning incentives.
• A dedicated $8,000,000 restricted stock unit pool is being established for Cycuity employees, which is a positive for employee retention and integration.
• The transaction is intended to qualify as a reorganization for U.S. federal income tax purposes, which can be beneficial for the tax treatment of the stock consideration for Cycuity shareholders.

Negatives

• A significant portion of the total consideration (up to $12,000,000) is contingent on achieving specific 2026 bookings milestones, introducing uncertainty for Cycuity shareholders.
• Portions of the merger consideration ($3,300,000 for indemnity and $330,000 for adjustments) will be held in escrow, delaying full payment to Cycuity shareholders and subject to potential claims.
• The final purchase price is subject to customary adjustments for Cycuity's closing cash, indebtedness, transaction expenses, and working capital, which could lead to a reduction in the final consideration.

Risks

• Failure to achieve the specified bookings milestones for the 2026 calendar year could result in no earnout payment, impacting the total consideration received by Cycuity shareholders.
• Indemnification claims against former Cycuity shareholders could reduce the amount released from the $3,300,000 indemnity escrow fund.
• Post-closing purchase price adjustments based on Cycuity's closing cash, indebtedness, transaction expenses, and working capital could lead to a reduction in the final consideration.
• Dissenting shareholders pursuing appraisal rights could result in additional costs for Arteris.
• The consummation of the mergers is subject to customary closing conditions, including Cycuity's stockholder approval, absence of prohibiting laws, accuracy of representations, and performance of covenants, any failure of which could prevent the transaction.
• The occurrence of a Material Adverse Effect on Cycuity between the agreement date and closing could lead to the termination of the merger agreement.

Future Outlook

Arteris intends to continue at least one significant historical business line of Cycuity or use a significant portion of Cycuity's historic business assets. Arteris covenants to use commercially reasonable efforts to sell Cycuity's products and services and will not take any action with the intent to reduce the earnout payment. Arteris will provide staffing substantially comparable to Cycuity's pre-closing levels and reasonably sufficient working capital, and will continue to make Cycuity's products available for sale. The earnout payments are contingent upon Cycuity achieving specified bookings milestones for the 2026 calendar year.

Management Comments

• Cycuity's board of directors unanimously determined that the mergers are advisable and fair to and in the best interests of the Company and its stockholders.
• Cycuity's board of directors unanimously adopted the Merger Agreement and unanimously recommended its adoption by the holders of Company Capital Stock.
• Arteris, Merger Sub I, Merger Sub II, and Cycuity intend that the Merger Agreement will be adopted as a plan of reorganization for purposes of Section 368 of the Code, and that the First Merger and Second Merger, taken together, shall qualify as a reorganization within the meaning of Section 368(a) of the Code.

Industry Context

The acquisition of Cycuity, a company focused on AI technologies and security (specifically its Radix product), by Arteris, a provider of network-on-chip (NoC) interconnect IP, signifies a strategic expansion into high-growth and critical technology segments. This move aligns with broader industry trends where semiconductor IP providers are integrating advanced capabilities like AI and robust security features directly into their offerings to meet the evolving demands of complex system-on-chip (SoC) designs and address increasing cybersecurity threats in hardware. This positions Arteris to offer more comprehensive solutions in areas like autonomous systems, data centers, and IoT, where secure and efficient AI processing is paramount.

Comparison to Industry Standards

• The inclusion of an earnout consideration, contingent on specific 2026 bookings milestones, is a common practice in technology acquisitions to bridge valuation gaps and incentivize post-merger performance, aligning seller interests with the buyer's strategic goals.
• The use of escrow funds for indemnity ($3,300,000) and purchase price adjustments ($330,000) is standard in M&A transactions to protect the buyer against unforeseen liabilities and ensure accuracy of closing financials, with the 12-month indemnity period being typical.
• The volume-weighted average price (VWAP) collar mechanism for valuing Arteris common stock ($12.42 $16.80) is a standard method to manage stock price volatility for stock-based consideration, providing a degree of price stability for both parties.
• The establishment of an $8,000,000 restricted stock unit pool for Cycuity employees is a customary retention strategy in technology mergers to ensure continuity of key talent and facilitate successful integration of the acquired business.

Management Changes

Corporate Governance

Legal Proceedings

• No actions are pending or threatened against Cycuity that question the validity of the transaction documents or Cycuity's right to consummate the contemplated transactions.
• Neither Cycuity nor its assets are subject to any governmental order specifically relating to Cycuity or its assets.
• No allegations of sexual harassment, sexual assault, sexual misconduct, gender discrimination, racial or ethnic discrimination, or similar behavior have been made against any officer, director, manager, or supervisory-level employee of Cycuity in the last 5 years.
• Cycuity has not entered into any settlement, tolling, non-disparagement, confidentiality, or non-disclosure agreements related to any misconduct allegations.

Related Party Transactions

• All agreements between Cycuity and its Related Parties (excluding ordinary course employment, severance, indemnification, or similar arrangements) will be terminated as of the Closing Date, with all obligations and liabilities canceled without further payment or liability for Cycuity.
• No Related Party has any direct or indirect interest in any asset used in the business, existing contracts (other than specified ordinary course agreements), asserted claims (other than compensation/reimbursement), or owes/is owed money (other than compensation/reimbursement).

Stakeholder Impact

• **Shareholders (Cycuity):** Will receive a mix of cash and Arteris common stock, with potential for additional earnout consideration. A portion of their consideration will be held in escrow for indemnity and adjustments. Unaccredited investors will receive cash instead of stock for certain portions.
• **Shareholders (Arteris):** Will experience dilution from the issuance of new common stock but gain a strategic asset in the AI and security markets, potentially enhancing long-term value.
• **Employees (Cycuity):** Key employees will enter into new employment agreements and restrictive covenants with Arteris. An $8,000,000 restricted stock unit pool is established for retention, aiming to secure their continued service and facilitate integration.
• **Customers (Cycuity):** Arteris has committed to continuing to make Cycuity's products available for sale and to use commercially reasonable efforts to sell them, suggesting continuity of service and product availability.
• **Creditors (Cycuity):** All outstanding Debt, including Convertible Notes, will be paid off at closing, resolving existing liabilities.

Next Steps

• Consummation of the First Merger and Second Merger.
• Filing of the First Certificate of Merger and Second Certificate of Merger with the Delaware Secretary of State.
• Cycuity to obtain the Required Stockholder Votes via written consents and deliver them to Arteris.
• Cycuity to prepare and send an information statement to its stockholders regarding the transaction and appraisal rights.
• Arteris to establish an $8,000,000 retention pool of restricted stock units for Cycuity employees.
• Parent and the Holder Representative will resolve any objections to post-closing adjustments within 75 days of the Closing Date.
• Earnout payments, if milestones are achieved, will be made by March 31, 2027.

Key Dates

Recommendation

The acquisition of Cycuity by Arteris represents a strategic move into the growing AI and security markets, which could enhance Arteris's long-term growth prospects. The earnout structure aligns the interests of the sellers with the future performance of the acquired business, and the retention pool for key employees suggests a commitment to successful integration. While there are inherent risks with earnouts and integration, the overall strategic rationale and the potential for market expansion make this a positive development for Arteris.

Keywords

Merger, Acquisition, Arteris, Cycuity, 8-K, SEC Filing, Earnout, Stock Consideration, Cash Consideration, Corporate Governance, Technology, Semiconductor IP, AI Technologies, Cybersecurity, Radix Product